Literature DB >> 15647183

Regulatory CD4+CD25+ cells reverse imbalances in the T cell pool of bone marrow transplanted TGepsilon26 mice leading to the prevention of colitis.

C Veltkamp1, R B Sartor, T Giese, F Autschbach, I Kaden, R Veltkamp, D Rost, B Kallinowski, W Stremmel.   

Abstract

BACKGROUND AND AIMS: Erroneous thymic selection of developing T lymphocytes may be responsible for the expansion of self reactive T cells or may contribute to the absence of regulatory T cells important in controlling peripheral inflammatory processes. Colitis in bone marrow (BM) transplanted Tgepsilon26 mice is induced by abnormally activated T cells developing in an aberrant thymic microenvironment. We investigated the protective role of regulatory CD4+CD25+ T cells in this model.
METHODS: BM from (C57BL/6 x CBA/J) F1 mice was transplanted into specific pathogen free Tgepsilon26 mice (BM-->Tgepsilon26). Transplanted mice received no cells (control), sorted CD4+CD25+, or CD4+CD25- cells from mesenteric lymph nodes (MLN) of normal mice. MLN cell subsets were analysed using membrane markers. Cytokine secretion of MLN cells was measured using intracellular cytokine staining and cytokine secretion in anti-CD3 stimulated cell cultures. Colitis was measured by histological scores.
RESULTS: CD4+CD25+ cells were reduced in the MLNs of BM-->Tgepsilon26 mice. Transfer of regulatory CD4CD4+CD25+ but not of CD4+CD25- cells reduced the number of MLN CD4+ T cells in BM-->Tgepsilon26 recipients and increased the number of MLN CD8+ cells, thereby normalising the CD4+/CD8+ ratio. CD4+CD25+ but not CD4+CD25- cell transfer into BM-->Tgepsilon26 mice reduced the number of tumour necrosis factor alpha+ CD4+ cells and increased the secretion of transforming growth factor beta by MLN cells. Transfer of 3 x 10(5) CD4+CD25+ cells after BM transplantation into Tgepsilon26 mice prevented colitis whereas CD4+CD25- cells had no protective effect.
CONCLUSIONS: These results suggest that defective selection or induction of regulatory T cells in the abnormal thymus is responsible for the development of colitis in BM-->Tgepsilon26 mice. Transfer of CD4+CD25+ cells can control intestinal inflammation in BM-->Tgepsilon26 mice by normalising the number and function of the MLN T cell pool.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647183      PMCID: PMC1774840          DOI: 10.1136/gut.2004.046953

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  41 in total

1.  Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice.

Authors:  C Veltkamp; S L Tonkonogy; Y P De Jong; C Albright; W B Grenther; E Balish; C Terhorst; R B Sartor
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

2.  CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.

Authors:  E Suri-Payer; A Z Amar; A M Thornton; E M Shevach
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

3.  Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes.

Authors:  G A Holländer; B Wang; A Nichogiannopoulou; P P Platenburg; W van Ewijk; S J Burakoff; J C Gutierrez-Ramos; C Terhorst
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

4.  Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis.

Authors:  S J Simpson; G A Holländer; E Mizoguchi; D Allen; A K Bhan; B Wang; C Terhorst
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

6.  Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis.

Authors:  F Mackay; J L Browning; P Lawton; S A Shah; M Comiskey; A K Bhan; E Mizoguchi; C Terhorst; S J Simpson
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

7.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

8.  Long-term human hematopoiesis in SCID-hu mice bearing transplanted fragments of adult bone and bone marrow cells.

Authors:  Y Heike; T Ohira; M Takahashi; N Saijo
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

9.  CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease.

Authors:  Y Cong; S L Brandwein; R P McCabe; A Lazenby; E H Birkenmeier; J P Sundberg; C O Elson
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  3 in total

1.  Diminution of Circulating CD4+CD25 high T cells in naïve Crohn's disease.

Authors:  Patrick Chamouard; Fanny Monneaux; Zoe Richert; Anne-Claire Voegeli; Thomas Lavaux; Marie Pierre Gaub; René Baumann; Pierre Oudet; Sylviane Muller
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

Review 2.  Inflammatory bowel disease: Moving toward a stem cell-based therapy.

Authors:  Giacomo Lanzoni; Giulia Roda; Andrea Belluzzi; Enrico Roda; Gian Paolo Bagnara
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

3.  Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis.

Authors:  Tessalia Diniz Luerce; Ana Cristina Gomes-Santos; Clarissa Santos Rocha; Thais Garcias Moreira; Déborah Nogueira Cruz; Luísa Lemos; Adna Luciana Sousa; Vanessa Bastos Pereira; Marcela de Azevedo; Kátia Moraes; Denise Carmona Cara; Jean Guy LeBlanc; Vasco Azevedo; Ana Maria Caetano Faria; Anderson Miyoshi
Journal:  Gut Pathog       Date:  2014-07-29       Impact factor: 4.181

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.